Koneksa Health

Koneksa Health is a New York-based digital health innovator founded in 2014, specializing in using digital biomarkers and AI to transform clinical evidence generation. The company offers a multimodal data platform and expert services that help biopharma clients design smarter, faster, and more patient-centric clinical trials. By unlocking novel signals from complex datasets, Koneksa aims to improve trial efficiency, enhance signal detection, and accelerate therapeutic development across neurology, oncology, respiratory, and rare diseases. It operates as a private, revenue-generating platform and services company trusted by industry leaders.

A sensor-agnostic SaaS platform for remote, patient-centric data collection and multimodal data integration. It combines digital biomarkers from wearables/mobile tech with traditional clinical data (Analog Endpoints) and supports advanced analytics, AI/ML model development (co-develop, license, or bring-your-own), and regulatory-grade digital endpoint operationalization.

Koneksa competes in a fragmented but rapidly consolidating market. Key competitors include large, traditional Contract Research Organizations (CROs) with digital divisions (e.g., IQVIA, Parexel), pure-play digital endpoint and DCT platform companies (e.g., Science 37, Medable), and tech giants with health initiatives (e.g., Apple, Verily). Koneksa differentiates through its deep focus on scientific validation, multimodal data integration, and flexible AI/ML model support, positioning itself as a specialist for complex biomarker strategies.